HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD Case Outcome Strikes Nerve For Both Advertiser, Challenger

This article was originally published in The Rose Sheet

Executive Summary

Perpetuating drama in the oral-care sector, Colgate-Palmolive is appealing a National Advertising Division ruling regarding advertising claims for its Sensitive Pro-Relief toothpaste and the validity of its supporting comparison studies. Challenger GlaxoSmithKline isn’t entirely satisfied with the decision either.

You may also be interested in...



NARB Upholds NAD Recommendations For Colgate Sensitive Ads

The advertising watchdog group’s appeals board confirms an earlier ruling that certain superiority claims made for a Colgate toothpaste product are not properly supported.

Colgate Bids To Expand U.S. Toothpaste Lineup Through FDA Rulemaking

Colgate seeks regulatory approval for a version of its Colgate Sensitive Multi-Protection toothpaste in a formulation it already markets internationally. The request made in a citizen petition comes after Colgate’s plan to expand its U.S. toothpaste business failed when FDA did not give approval for Sensitive Pro-Relief with arginine.

Crest Claims Of Fast Sensitivity Relief Fail Colgate’s NAD Challenge

UsernamePublicRestriction

Register

RS018066

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel